Today: 21 April 2026
Why Accenture Stock Is Sliding Ahead of March 19 Earnings After Truist Target Cut
10 March 2026
1 min read

Why Accenture Stock Is Sliding Ahead of March 19 Earnings After Truist Target Cut

NEW YORK, March 10, 2026, 16:16 EDT

Accenture dropped roughly 3.7% Tuesday, trading around $201.62 late in the day, after Truist slashed its price target and flagged “possible ecosystem pressures” heading into the consulting giant’s March 19 earnings. StreetInsider.com

The timing comes with Accenture’s second-quarter results only nine days out. That’s adding urgency to a key sector doubt: are AI services bringing in sufficient new business to balance out weak partner spending and softness in legacy consulting?

Truist’s Arvind Ramnani dropped his price target on Accenture to $260, down from $317, though he’s sticking with his Buy call. He cited sluggish AI adoption across enterprises, adding that fiscal 2027 projections could face trouble if tech partners in Accenture’s ecosystem pull back on spending—or if AI simply replaces current business rather than boosting it.

Accenture slid 1.2% by late Tuesday, a steeper drop than IBM, while Cognizant fared worse, losing around 2.6%. The move put Accenture under heavier strain than certain other IT services names.

Dealmaking has been Accenture’s response to those concerns. On March 3, the company announced it would release results on March 19. That same day, Reuters reported Accenture reached a $1.2 billion cash agreement to acquire Ziff Davis’s Connectivity segment—home to Ookla’s Speedtest and the Downdetector outage tracker.

“With the Ookla portfolio, we will offer end-to-end network intelligence services essential for AI-based transformation,” said Manish Sharma, Accenture’s chief strategy and services officer, when the deal was announced. The acquisition brings in network data and analytics assets to back Accenture’s push for AI-driven client work. Reuters

Accenture’s most recent quarterly results sent a muddled message. Back in December, Reuters noted the company topped first-quarter revenue projections thanks to robust AI services demand. However, the outlook for second-quarter revenue landed with a midpoint under what Wall Street was looking for, and Accenture pointed to choppy demand among government and public-sector customers.

That pressure hasn’t gone away. Back in March, Accenture pointed to U.S. government cost reductions as the reason for delayed and canceled contracts, noting its federal business made up roughly 8% of this year’s revenue. “Accenture’s revenue faces headwinds due to the Trump administration’s focus on federal cost cutting,” said Michael Ashley Schulman, chief investment officer at Running Point Capital at the time. Reuters

Still, some analysts aren’t dialing back expectations. Last week, TD Cowen’s Bryan Bergin pointed to steady second-quarter results and guidance, saying concerns about “AI-driven narrative pressure” might be exaggerated. He did note that it’s tough to expect a dramatic shift in sentiment from just one report. Investing.com

The next report might go either way. Bookings will be key for investors, since those signed deals signal upcoming revenue. If there’s any hint that AI is eating into legacy business faster than fresh AI projects are coming in, expect more estimate cuts after March 19.

Stock Market Today

  • Apple's Next CEO Named, Kevin Warsh's Fed Hearing, Nasdaq Streak Ends
    April 21, 2026, 9:01 AM EDT. Apple announced John Ternus will succeed Tim Cook as CEO in September, with Cook moving to executive chairman. Investors reacted with surprise but viewed Ternus' hardware expertise as positive amid Apple's need to catch up on artificial intelligence. Meanwhile, Kevin Warsh, Trump's pick for Federal Reserve chair, faces a Senate Banking Committee confirmation hearing today, expected to focus on his political independence and Wall Street ties. On Wall Street, the Nasdaq Composite snapped its longest winning streak since 1992, and the S&P 500 had its first decline in six sessions amid rising geopolitical tensions involving Iran.

Latest article

Silver Price Today Drops Below $79 as Dollar, Oil Risks Shake Traders

Silver Price Today Drops Below $79 as Dollar, Oil Risks Shake Traders

21 April 2026
Spot silver dropped below $79 an ounce Tuesday, with Kitco quoting $78.87 bid, down 0.93%, as a stronger dollar and higher yields pressured precious metals. Silver remains up 14% for the month and over 140% year-on-year, making it vulnerable to profit-taking. Oil prices eased after a Monday spike, while shipping through the Strait of Hormuz stayed limited amid U.S.-Iran tensions. Germany’s ZEW investor morale index fell to minus 17.2 in April.
Natural Gas Price Today Slips Near $2.67 as Storage Cushion Blunts LNG Demand Boost

Natural Gas Price Today Slips Near $2.67 as Storage Cushion Blunts LNG Demand Boost

21 April 2026
U.S. natural gas futures slipped to around $2.67 per mmBtu early Tuesday after settling at $2.689 on Monday, ending a four-session rally. Storage levels remain above normal, with 1,970 billion cubic feet reported April 10, capping price gains despite colder forecasts. LNG exports are near record highs but terminals have little spare capacity. The EIA projects inventories will stay above the five-year average through October.
Oil Price Today: Brent Drops Below $95 as U.S.-Iran Talks Test the Market’s Biggest Risk

Oil Price Today: Brent Drops Below $95 as U.S.-Iran Talks Test the Market’s Biggest Risk

21 April 2026
Brent crude fell below $95 a barrel Tuesday as traders focused on possible U.S.-Iran peace talks, despite ongoing disruption in the Strait of Hormuz. Brent futures dropped 69 cents to $94.79, while U.S. WTI for May lost $1.12 to $88.49. The IEA said Middle East outages cut global oil supply by 10.1 million barrels per day in March, the largest disruption on record. U.S. crude exports are rising but cannot fully replace lost Middle East shipments.
AbbVie Obesity Drug ABBV-295 Hits Up to 9.8% Weight Loss in Early Trial
Previous Story

AbbVie Obesity Drug ABBV-295 Hits Up to 9.8% Weight Loss in Early Trial

KLA Corporation stock rises as Barclays lifts chip-equipment outlook ahead of investor day
Next Story

KLA Corporation stock rises as Barclays lifts chip-equipment outlook ahead of investor day

Go toTop